tradingkey.logo
tradingkey.logo
Search

Labcorp Holdings Inc

LH
Add to Watchlist
271.470USD
0.0000.00%
Close 06/26, 16:00ETQuotes delayed by 15 min
22.34BMarket Cap
23.89P/E TTM

Labcorp Holdings Inc

271.470
0.0000.00%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+6.12%

1 Month

+5.12%

6 Months

+6.92%

Year to Date

+8.21%

1 Year

+4.18%

Key Figures
--Open
0.000High
0.00Volume
23.89P/E TTM
13.18P/E Dynamic
2.880Dividend TTM
1.26%Turnover Ratio
271.470Prev. Close
0.000Low
0.00Turnover
29.95P/E Static
2.56P/B
1.06%Div Yield TTM
5.14%ROA
293.72052wk High
1.41Volume Ratio
746.00MNet Profit
82.30MShares
11.3649EPS TTM
0.91Beta
11.05%ROE
241.81052wk Low
2.01%Amplitude
26.52%Gross Margin
22.34BMarket Cap
1.04Reward/Risk
1.32%Risk Rate

TradingKey Stock Score of Labcorp Holdings Inc

Currency: USD Updated: 2026-06-26

Key Insights

Labcorp Holdings Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 5 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 307.35.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Labcorp Holdings Inc's Score

Industry at a Glance

Industry Ranking
5 / 76
Overall Ranking
36 / 4566
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

19°C

Very Low
Very High
Negative-

Labcorp Holdings Inc Highlights

StrengthsRisks
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 13.95B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 32.56%.
Undervalued
The company’s latest PE is 23.89, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 88.74M shares, increasing 5.91% quarter-over-quarter.
Held by Wallace Weitz
Star Investor Wallace Weitz holds 102.34K shares of this stock.

Analyst Rating

Based on 20 analysts
Buy
Current Rating
307.347
Target Price
+18.85%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Labcorp Holdings Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Labcorp Holdings Inc Info

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and accelerates to improve health and improve lives through its unparalleled diagnostics and drug development capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Ticker SymbolLH
CompanyLabcorp Holdings Inc
CEOSchechter (Adam H)
Websitehttps://www.labcorp.com/

FAQs

What is the current price of Labcorp Holdings Inc (LH)?

The current price of Labcorp Holdings Inc (LH) is 271.47.

What is the symbol of Labcorp Holdings Inc?

The ticker symbol of Labcorp Holdings Inc is LH.

What is the 52-week high of Labcorp Holdings Inc?

The 52-week high of Labcorp Holdings Inc is 293.72.

What is the 52-week low of Labcorp Holdings Inc?

The 52-week low of Labcorp Holdings Inc is 241.81.

What is the market capitalization of Labcorp Holdings Inc?

The market capitalization of Labcorp Holdings Inc is 22.34B.

Is Labcorp Holdings Inc (LH) currently rated as Buy, Hold, or Sell?

According to analysts, Labcorp Holdings Inc (LH) has an overall rating of Buy, with a price target of 307.35.

What is the Earnings Per Share (EPS TTM) of Labcorp Holdings Inc (LH)?

The Earnings Per Share (EPS TTM) of Labcorp Holdings Inc (LH) is 10.53.
KeyAI